An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
- Sprache
-
Englisch
- Identifier
-
1189418088
Beteiligte Personen und Organisationen
Sommerer, Claudia
Suwelack, Barbara
Dragun, Duska
Schenker, Peter
Hauser, Ingeborg A.
Witzke, Oliver
Hugo, Christian
Kamar, Nassim
Merville, Pierre
Junge, Martina
Thaiss, Friedrich
Nashan, Björn
Suwelack, Barbara
Dragun, Duska
Schenker, Peter
Hauser, Ingeborg A.
Witzke, Oliver
Hugo, Christian
Kamar, Nassim
Merville, Pierre
Junge, Martina
Thaiss, Friedrich
Nashan, Björn
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Beteiligte
- Sommerer, Claudia
- Suwelack, Barbara
- Dragun, Duska
- Schenker, Peter
- Hauser, Ingeborg A.
- Witzke, Oliver
- Hugo, Christian
- Kamar, Nassim
- Merville, Pierre
- Junge, Martina
- Thaiss, Friedrich
- Nashan, Björn
Ähnliche Objekte (12)
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Immunological risk assessment: the key to individualized immunosuppression after kidney transplantation
Status of periodontal health in German patients suffering from chronic kidney disease - data from the GCKD study
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients
Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients
Kostimulatorische Marker auf follikulären T-Helferzellen in Patienten mit systemischem Lupus erythematodes (SLE)
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Immunological risk assessment: the key to individualized immunosuppression after kidney transplantation
Status of periodontal health in German patients suffering from chronic kidney disease - data from the GCKD study
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients
Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients
Kostimulatorische Marker auf follikulären T-Helferzellen in Patienten mit systemischem Lupus erythematodes (SLE)
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Immunological risk assessment: the key to individualized immunosuppression after kidney transplantation
Status of periodontal health in German patients suffering from chronic kidney disease - data from the GCKD study
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
Sex-associated differences in cytomegalovirus prevention: prophylactic strategy is potentially associated with a strong kidney function impairment in female renal transplant patients
Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients